Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:doravirine
|
| gptkbp:approvalYear |
2018
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:J05AG06
|
| gptkbp:contraindication |
coadministration with St. John's wort
coadministration with carbamazepine coadministration with rifampin |
| gptkbp:drugClass |
non-nucleoside reverse transcriptase inhibitor
|
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pifeltro
|
| gptkbp:manufacturer |
gptkb:Merck_&_Co.
|
| gptkbp:mechanismOfAction |
inhibits HIV-1 reverse transcriptase
|
| gptkbp:pregnancyCategory |
N/A (consult physician)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
diarrhea fatigue headache |
| gptkbp:usedFor |
HIV-1 infection
|
| gptkbp:bfsParent |
gptkb:MRK
|
| gptkbp:bfsLayer |
5
|